25.9 USD
+0.08 (+0.31%)
Overall CCLDO gets a fundamental rating of 5 out of 10. We evaluated CCLDO against 35 industry peers in the Health Care Technology industry. CCLDO has only an average score on both its financial health and profitability. While showing a medium growth rate, CCLDO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year CCLDO was profitable.
- CCLDO had a positive operating cash flow in the past year.
- In the past 5 years CCLDO always reported negative net income.
- CCLDO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- CCLDO's Return On Assets of 2.63% is amongst the best of the industry. CCLDO outperforms 88.57% of its industry peers.
- The Return On Equity of CCLDO (4.12%) is better than 85.71% of its industry peers.
- CCLDO's Return On Invested Capital of 13.98% is amongst the best of the industry. CCLDO outperforms 94.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROIC | 13.98% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.08%, CCLDO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
- CCLDO has a better Operating Margin (10.43%) than 88.57% of its industry peers.
- In the last couple of years the Operating Margin of CCLDO has grown nicely.
- With a Gross Margin value of 46.49%, CCLDO is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of CCLDO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
- CCLDO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- CCLDO has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CCLDO has more shares outstanding
- CCLDO has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 20.91 indicates that CCLDO is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 20.91, CCLDO belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
- CCLDO has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.38, CCLDO is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
- A Debt/Equity ratio of 0.12 indicates that CCLDO is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.12, CCLDO perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Altman-Z | 20.91 |
ROIC/WACC1.44
WACC9.74%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that CCLDO should not have too much problems paying its short term obligations.
- CCLDO's Current ratio of 1.26 is on the low side compared to the rest of the industry. CCLDO is outperformed by 74.29% of its industry peers.
- A Quick Ratio of 1.15 indicates that CCLDO should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.15, CCLDO is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
- CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.27%, which is quite impressive.
- The Revenue has been growing slightly by 2.97% in the past year.
- CCLDO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
3.2 Future
- CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 61.62% yearly.
- The Revenue is expected to grow by 9.34% on average over the next years. This is quite good.
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 647.50, CCLDO can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, CCLDO is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
- CCLDO's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.47.
- A Price/Forward Earnings ratio of 211.60 indicates a quite expensive valuation of CCLDO.
- CCLDO's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of CCLDO to the average of the S&P500 Index (24.26), we can say CCLDO is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 647.5 | ||
| Fwd PE | 211.6 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as CCLDO.
- CCLDO's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.67 | ||
| EV/EBITDA | 41.68 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCLDO does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of CCLDO may justify a higher PE ratio.
- CCLDO's earnings are expected to grow with 61.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.44
PEG (5Y)N/A
EPS Next 2Y61.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 7.75%, CCLDO is a good candidate for dividend investing.
- CCLDO's Dividend Yield is rather good when compared to the industry average which is at 0.54. CCLDO pays more dividend than 97.14% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.75% |
5.2 History
- CCLDO has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y61.62%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (1/16/2026, 8:00:02 PM)
25.9
+0.08 (+0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-11 2026-03-11/amc
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)114.31M
Net Income(TTM)2.38M
Analysts80
Price Target45.4 (75.29%)
Short Float %0.01%
Short Ratio0.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.75% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)30.72%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)6.7%
EPS beat(12)8
Avg EPS beat(12)0.7%
EPS beat(16)12
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)2.58%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.44%
Revenue beat(4)2
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.44%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)3
Avg Revenue beat(16)-2.05%
PT rev (1m)-1.56%
PT rev (3m)47.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)12.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 647.5 | ||
| Fwd PE | 211.6 | ||
| P/S | 9.61 | ||
| P/FCF | 60.67 | ||
| P/OCF | 43.02 | ||
| P/B | 19 | ||
| P/tB | 178.97 | ||
| EV/EBITDA | 41.68 |
EPS(TTM)0.04
EY0.15%
EPS(NY)0.12
Fwd EY0.47%
FCF(TTM)0.43
FCFY1.65%
OCF(TTM)0.6
OCFY2.32%
SpS2.7
BVpS1.36
TBVpS0.14
PEG (NY)4.44
PEG (5Y)N/A
Graham Number1.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROCE | 17.7% | ||
| ROIC | 13.98% | ||
| ROICexc | 14.93% | ||
| ROICexgc | 82.32% | ||
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% | ||
| FCFM | 15.84% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score6
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 51.55% | ||
| Cap/Sales | 6.5% | ||
| Interest Coverage | 118.08 | ||
| Cash Conversion | 96.95% | ||
| Profit Quality | 760.91% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 20.91 |
F-Score6
WACC9.74%
ROIC/WACC1.44
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.34%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year219.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y212.1%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y43.66%
OCF growth 3Y15.69%
OCF growth 5Y22.06%
CARECLOUD INC - CCLD 8 3/4 PERP / CCLDO FAQ
What is the ChartMill fundamental rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCLDO.
What is the valuation status of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
ChartMill assigns a valuation rating of 3 / 10 to CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO). This can be considered as Overvalued.
How profitable is CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) has a profitability rating of 6 / 10.
What is the expected EPS growth for CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
The Earnings per Share (EPS) of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) is expected to grow by 145.9% in the next year.